-
WDNA Dashboard
- Holdings
WisdomTree BioRevolution Fund
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
NTRA Natera, Inc. | 86.27 k | 545.00 shares | 4.00 | Common equity | Long | USA |
TWST Twist Bioscience Corporation | 79.88 k | 1.72 k shares | 3.71 | Common equity | Long | USA |
Novonesis (Novozymes) B
|
59.61 k | 1.05 k shares | 2.77 | Common equity | Long | Denmark |
VCEL Vericel Corporation | 58.48 k | 1.07 k shares | 2.71 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 52.86 k | 606.00 shares | 2.45 | Common equity | Long | USA |
VCYT Veracyte, Inc. | 52.71 k | 1.33 k shares | 2.44 | Common equity | Long | USA |
LLY Eli Lilly and Company | 49.41 k | 64.00 shares | 2.29 | Common equity | Long | USA |
GERN Geron Corporation | 48.20 k | 13.62 k shares | 2.24 | Common equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 42.50 k | 1.55 k shares | 1.97 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals, Inc. | 40.12 k | 1.22 k shares | 1.86 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 39.17 k | 111.00 shares | 1.82 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics, Inc. | 35.43 k | 4.79 k shares | 1.64 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 35.02 k | 288.00 shares | 1.62 | Common equity | Long | USA |
DREY INST PREF GOV MM-M | 34.70 k | 34.70 k shares | 1.61 | Short-term investment vehicle | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 32.24 k | 137.00 shares | 1.50 | Common equity | Long | USA |
NEO NeoGenomics, Inc. | 31.08 k | 1.89 k shares | 1.44 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 31.01 k | 77.00 shares | 1.44 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 30.94 k | 335.00 shares | 1.44 | Common equity | Long | USA |
DHR Danaher Corporation | 30.53 k | 133.00 shares | 1.42 | Common equity | Long | USA |
DD DuPont de Nemours, Inc. | 29.89 k | 392.00 shares | 1.39 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 29.62 k | 704.00 shares | 1.37 | Common equity | Long | USA |
Novartis AG
|
29.46 k | 301.00 shares | 1.37 | Common equity | Long | Switzerland |
BMY Bristol-Myers Squibb Company | 29.07 k | 514.00 shares | 1.35 | Common equity | Long | USA |
LH Laboratory Corporation of America Holdings | 28.44 k | 124.00 shares | 1.32 | Common equity | Long | USA |
FOLD Amicus Therapeutics, Inc. | 28.39 k | 3.01 k shares | 1.32 | Common equity | Long | USA |
QGEN Qiagen N.V. | 27.70 k | 622.00 shares | 1.28 | Common equity | Long | Netherlands |
AMGN Amgen Inc. | 27.63 k | 106.00 shares | 1.28 | Common equity | Long | USA |
TSN Tyson Foods, Inc. | 27.57 k | 480.00 shares | 1.28 | Common equity | Long | USA |
BNTX BioNTech SE | 27.12 k | 238.00 shares | 1.26 | Common equity | Long | Germany |
CTVA Corteva, Inc. | 26.89 k | 472.00 shares | 1.25 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 26.21 k | 1.06 k shares | 1.22 | Common equity | Long | USA |
ZTS Zoetis Inc. | 26.07 k | 160.00 shares | 1.21 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 26.01 k | 50.00 shares | 1.21 | Common equity | Long | USA |
JNJ Johnson & Johnson | 25.31 k | 175.00 shares | 1.17 | Common equity | Long | USA |
Syensqo SA
|
25.21 k | 345.00 shares | 1.17 | Common equity | Long | Belgium |
STOK Stoke Therapeutics, Inc. | 25.16 k | 2.28 k shares | 1.17 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 24.82 k | 710.00 shares | 1.15 | Common equity | Long | USA |
RGEN Repligen Corporation | 24.76 k | 172.00 shares | 1.15 | Common equity | Long | USA |
MRK Merck & Co., Inc. | 24.67 k | 248.00 shares | 1.14 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 24.22 k | 34.00 shares | 1.12 | Common equity | Long | USA |
AZN AstraZeneca PLC | 24.11 k | 368.00 shares | 1.12 | Common equity | Long | UK |
TECH Bio-Techne Corporation | 23.77 k | 330.00 shares | 1.10 | Common equity | Long | USA |
ILMN Illumina, Inc. | 23.65 k | 177.00 shares | 1.10 | Common equity | Long | USA |
DAR Darling Ingredients Inc. | 23.65 k | 702.00 shares | 1.10 | Common equity | Long | USA |
EXAS Exact Sciences Corporation | 23.60 k | 420.00 shares | 1.09 | Common equity | Long | USA |
CRSP CRISPR Therapeutics AG | 22.55 k | 573.00 shares | 1.05 | Common equity | Long | Switzerland |
Arcturus Therapeutics Holdings, Inc. | 22.40 k | 1.32 k shares | 1.04 | Common equity | Long | USA |
Takeda Pharmaceutical Co Ltd
|
21.07 k | 792.00 shares | 0.98 | Common equity | Long | Japan |
BIO Bio-Rad Laboratories, Inc. | 21.02 k | 64.00 shares | 0.98 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 20.85 k | 1.52 k shares | 0.97 | Common equity | Long | USA |
DOW Dow Inc. | 20.83 k | 519.00 shares | 0.97 | Common equity | Long | USA |
GMAB Genmab A/S | 20.29 k | 972.00 shares | 0.94 | Common equity | Long | Denmark |
ARGX argenx SE | 19.68 k | 32.00 shares | 0.91 | Common equity | Long | Netherlands |
ARWR Arrowhead Pharmaceuticals, Inc. | 18.74 k | 997.00 shares | 0.87 | Common equity | Long | USA |
PFE Pfizer Inc. | 18.52 k | 698.00 shares | 0.86 | Common equity | Long | USA |
ADM Archer-Daniels-Midland Company | 18.09 k | 358.00 shares | 0.84 | Common equity | Long | USA |
FATE Fate Therapeutics, Inc. | 18.08 k | 10.96 k shares | 0.84 | Common equity | Long | USA |
NTR Nutrien Ltd. | 17.54 k | 392.00 shares | 0.81 | Common equity | Long | Canada |
SDGR Schrödinger, Inc. | 17.50 k | 907.00 shares | 0.81 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 17.42 k | 265.00 shares | 0.81 | Common equity | Long | USA |
BHVN Biohaven Ltd. | 15.57 k | 417.00 shares | 0.72 | Common equity | Long | USA |
ACLX Arcellx, Inc. | 15.41 k | 201.00 shares | 0.72 | Common equity | Long | USA |
Bayer AG
|
15.38 k | 769.00 shares | 0.71 | Common equity | Long | Germany |
RVMD Revolution Medicines, Inc. | 14.83 k | 339.00 shares | 0.69 | Common equity | Long | USA |
BIIB Biogen Inc. | 14.53 k | 95.00 shares | 0.67 | Common equity | Long | USA |
Lenzing AG
|
14.51 k | 475.00 shares | 0.67 | Common equity | Long | Austria |
FMC FMC Corporation | 14.19 k | 292.00 shares | 0.66 | Common equity | Long | USA |
SPOT Spotify Technology S.A. | 13.15 k | 1.34 k shares | 0.61 | Common equity | Long | USA |
Nufarm Ltd
|
12.66 k | 5.78 k shares | 0.59 | Common equity | Long | Australia |
RGNX REGENXBIO Inc. | 12.38 k | 1.60 k shares | 0.57 | Common equity | Long | USA |
VERV Verve Therapeutics, Inc. | 12.38 k | 2.19 k shares | 0.57 | Common equity | Long | USA |
TEM Tempus AI, Inc. | 12.32 k | 365.00 shares | 0.57 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 11.90 k | 5.59 k shares | 0.55 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc. | 11.72 k | 432.00 shares | 0.54 | Common equity | Long | USA |
CVAC CureVac N.V. | 11.35 k | 3.33 k shares | 0.53 | Common equity | Long | Germany |
NxStage Medical, Inc. | 11.26 k | 6.15 k shares | 0.52 | Common equity | Long | USA |
GNS Genius Group Limited | 10.83 k | 558.00 shares | 0.50 | Common equity | Long | UK |
ORGN Origin Materials, Inc. | 10.64 k | 8.31 k shares | 0.49 | Common equity | Long | USA |
Oxford Nanopore Technologies PLC
|
10.29 k | 6.38 k shares | 0.48 | Common equity | Long | UK |
CRBU Caribou Biosciences, Inc. | 9.77 k | 6.14 k shares | 0.45 | Common equity | Long | USA |
GPRE Green Plains Inc. | 9.76 k | 1.03 k shares | 0.45 | Common equity | Long | USA |
TXG 10x Genomics, Inc. | 9.62 k | 670.00 shares | 0.45 | Common equity | Long | USA |
Takara Bio Inc
|
9.35 k | 1.40 k shares | 0.43 | Common equity | Long | Japan |
NTLA Intellia Therapeutics, Inc. | 8.97 k | 769.00 shares | 0.42 | Common equity | Long | USA |
BYND Beyond Meat, Inc. | 8.78 k | 2.34 k shares | 0.41 | Common equity | Long | USA |
MRNA Moderna, Inc. | 8.02 k | 193.00 shares | 0.37 | Common equity | Long | USA |
Solvay SA
|
7.61 k | 236.00 shares | 0.35 | Common equity | Long | Belgium |
Verbio SE
|
6.90 k | 563.00 shares | 0.32 | Common equity | Long | Germany |
ABSI Absci Corporation | 6.57 k | 2.51 k shares | 0.30 | Common equity | Long | USA |
EDIT Editas Medicine, Inc. | 5.71 k | 4.49 k shares | 0.26 | Common equity | Long | USA |
SANA Sana Biotechnology, Inc. | 4.76 k | 2.92 k shares | 0.22 | Common equity | Long | USA |
DREYFUS TRSY OBLIG CASH M | 860.42 | 860.42 shares | 0.04 | Short-term investment vehicle | Long | USA |